
Keywords: AGEs; advanced glycation endproducts; BMD; bone mineral density; CAH; congenital adrenal hyperplasia; DM; diabetes mellitus; DPP-4; dipeptydil petptidase-4; DXA; dual-energy X-ray absorptiometry; FRAX; fracture risk assessment tool; FSH; follicle stimulat